Today: 10/08/2022 18:30:20 (GMT+7)
THE CENTRAL AGENCY OF THE COMMUNIST PARTY OF VIETNAM BAC GIANG PROVINCE THE VOICE OF THE PARTY, GOVERNMENT AND PEOPLE OF BAC GIANG PROVINCE

Ministry licences three domestically-produced Molnupiravir drugs to treat Covid-19

The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three Covid-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.

The three drugs are Molravir 400 produced by Boston Vietnam Pharma; Movinavir 200 mg manufactured by Mekophar Chemical Pharmaceutical; and Molnupiravir Stella 400 produced by Stellapharm J.V Co., Ltd.

Ministry licences, three domestically-produced drugs, Molnupiravir drug, treat Covid-19 pandemic, Drug Administration of Vietnam, active ingredient

Ministry licences three domestically-produced Molnupiravir drugs to treat Covid-19.

Earlier, the advisory council of the Ministry of Health agreed with the latter's proposal on granting certificates of registration for conditional circulation to the three drugs. The licensing for these drugs is valid for three years from the date of signing the decision.

The DAV requested drug manufacturing and registration establishments to produce in accordance with dossiers and documents registered with the Ministry of Health, coordinate with treatment facilities to strictly comply with current regulations on prescription drugs, monitor the safety, effectiveness, and unwanted effects of drugs on Vietnamese people, and report it regularly.

The DAV also asked the Departments of Health of provinces and centrally-run cities to direct local medical examination and treatment facilities, medical staff, and drug supply establishments to notify patients of the benefits and risks when using these drugs, treatment methods, other drugs that can replace Molnupiravir in treating Covid-19.

During the circulation of the three drugs, based on the monitoring and updating information on the safety and effectiveness of them, the agency may decide to revoke the granted certificates of registration for circulation in line with Clause 1, Article 58 of the Law on Pharmacy.

New Covid-19 cases on February 17
The number of Covid-19 cases detected in the past 24 hours from 4pm February 16 to 4pm February 17 rose by 1,467 from the previous day to 36,200, including 10 imported cases, according to the Ministry of Health.
 
Home quarantine for Covid-19 patients shortened to 7 days
The Covid-19 patients under home treatment will no longer be isolated after undergoing quarantine and treatment for seven days, instead of 10 days like in the past, and their rapid antigen test result is negative.
 
Hanoi builds plans to ensure flexible adaptation to COVID-19 at SEA Games 31
The People’s Committee of Hanoi has outlined three Covid-19 prevention and control plans to ensure the successful organisation of the opening and closing ceremonies of the 31st Southeast Asian Games (SEA Games 31) in the capital city in May.
 
Covid figures on February 16
Covid figures on February 16. 
 
31,814 new Covid-19 cases, 85 more deaths reported on Tuesday
31,814 new Covid-19 cases, 85 more deaths reported on Tuesday.
 

Source: NDO/VNA

Ministry licences, three domestically-produced drugs, Molnupiravir drug, treat Covid-19 pandemic, Drug Administration of Vietnam, active ingredient
 
New comment has just been added. Click here
Sort:NewBest News